Dealing with Uncertainty – Experiences, Challenges and Opportunities

Within the Pharma industry, Competitive Intelligence is becoming established as providing vital support in enabling strategy and decision making at a cross-functional level. However, with increasing complexities surrounding competitive assumptions and the opportunities/challenges they impact within a global environment, many CI professionals find it increasingly difficult to move beyond the “information” provider to “thought-partner” for their stakeholders. At INOVIS, we are progressively dealing with clients struggling to deal with the unknown, with the fear of uncertainty greatly contributing to a lack of agility and competitive fitness across organizations.

Participants will benefit from the vast experience of the presenters and take home ideas and practical considerations to immediately implement as part of their working practices. Moreover, by strengthening and leveraging their client relationships, drawing on specific expertise and experience, CI professionals should leave with more confidence in dealing with the unknown and turning these challenging situations to their opportunity!

Key topics

  • Real-world examples from Pharma professionals, where overarching uncertainties have impacted business issues
  • How was uncertainty addressed?
  • What are the learnings?
  • How can CI - be it a mindset or specific framework(s) - generate actionable and tangible outcomes to support the current pharma business environment?
  • What are the opportunities for high-impact/high value vendor-client activities to better support this area?

Speaker profile

Deniss Engelke joined Jazz Pharmaceuticals in 2015, Dennis has been working in the International Portfolio Planning team responsible for the analysis and monitoring of the current Haematology and Oncology business by providing commercial insights which meaningfully improve brand strategies across the International region. In addition, he is assessing development assets or acquisition targets, contributing towards the final Go/No-Go decision. 

He is working in close collaboration with the commercial, medical, and business development leadership teams ensuring identification of insights, transfer of best practice and a holistic assessment of new product targets. 

Dennis has 10 years of hands-on experience in the innovative and generic pharmaceutical industry and held previously global strategic marketing, business development and business intelligence positions for Specialty Pharmaceuticals at Actelion Pharmaceuticals and Fresenius Kabi. 

He holds a Master degree in Business and Economics from the Universities of Hamburg (Germany) and Uppsala (Sweden)

Speaker profile

Baljit Singh (Ph.D.)
Managing Director and Partner, Global Pharmaceuticals and Life Sciences Division